Analytics, if designed meaningfully, can empower providers, patients, families and communities. Recognizing the ability of population health analytics to support community partners and directly impact patient care, Aspenti has developed an internal population health analytics team and a versatile custom business analytic tool. To deliver the most impactful data, Aspenti leverages our strategic partnerships to gain insights into social determinants of health and align those with emerging drug trends in a meaningful way for our providers.
Using laboratory data alone, we can gain insights into emerging drug trends, treatment adherence and the frequency of unexpected findings.
Frequency Utilization Report
One of the key drivers of costs associated with urine drug testing is the frequency of testing. Our reports provide visibility into testing frequencies and are categorized based on CMS-derived local coverage determination guidance for urine drug testing. Furthermore, we are expanding our metrics into test frequency by benchmarking against local providers, as well as stratifying by disease state (active or remission) and by time in care.
Heat Map Analytics
We have given visibility to community partners on county-level drug use demonstrating marked variability in buprenorphine adherence as well as in fentanyl and heroin use. Aspenti further partitions geospatial data into specialized catchment areas which are important to the requesting organization. By working in partnership with providers, we can define organization-specific indicators to delineate geo-boundaries for customized heatmaps. Examples include city wards, collection sites, or facilities of residence.
Patient Population Metrics Report (PPM)
Used to optimize testing for more focused treatment, and to enhance visibility to local and regional drug use patterns based on the rates of positive testing. This report arms our clients with how often their orders detect drug use, enabling providers to focus their testing in light of trends in their unique patient population. By highlighting the number of confirmation tests ordered, clients can select testing strategies that both optimize patient care, and enable them to be stewards of limited health care resources in this era of value-based care.